News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
165,783 Results
Type
Article (11432)
Company Profile (9)
Press Release (154342)
Multimedia
Podcasts (35)
Webinars (1)
Section
Business (53350)
Career Advice (623)
Deals (7614)
Drug Delivery (37)
Drug Development (35164)
Employer Resources (38)
FDA (4664)
Job Trends (3950)
News (97393)
Policy (7435)
Tag
Academia (590)
Accelerated approval (17)
Adcomms (14)
Allergies (58)
Alliances (7635)
ALS (67)
Alzheimer's disease (511)
Antibody-drug conjugate (ADC) (132)
Approvals (4805)
Artificial intelligence (89)
Autoimmune disease (63)
Automation (3)
Bankruptcy (57)
Best Places to Work (3426)
BIOSECURE Act (5)
Biosimilars (60)
Biotechnology (4)
Bladder cancer (85)
Brain cancer (22)
Breast cancer (245)
Cancer (1889)
Cardiovascular disease (156)
Career advice (523)
Career pathing (13)
CAR-T (107)
CDC (14)
Cell therapy (247)
Cervical cancer (13)
Clinical research (31965)
Collaboration (290)
Company closure (2)
Compensation (145)
Complete response letters (25)
COVID-19 (1063)
CRISPR (22)
C-suite (106)
Cystic fibrosis (47)
Data (2480)
Denatured (4)
Depression (62)
Diabetes (177)
Diagnostics (1352)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (39)
Drug pricing (61)
Drug shortages (7)
Duchenne muscular dystrophy (84)
Earnings (41122)
Editorial (21)
Employer branding (7)
Employer resources (35)
Events (17857)
Executive appointments (91)
FDA (5913)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (313)
Gene editing (52)
Generative AI (10)
Gene therapy (214)
GLP-1 (392)
Government (1196)
Grass and pollen (4)
Guidances (251)
Healthcare (4133)
HIV (17)
Huntington's disease (22)
IgA nephropathy (49)
Immunology and inflammation (112)
Immuno-oncology (20)
Indications (44)
Infectious disease (1145)
Inflammatory bowel disease (58)
Inflation Reduction Act (10)
Influenza (31)
Intellectual property (55)
Interviews (118)
IPO (4492)
IRA (24)
Job creations (666)
Job search strategy (412)
JPM (17)
Kidney cancer (11)
Labor market (27)
Layoffs (227)
Leadership (8)
Legal (885)
Liver cancer (50)
Lung cancer (307)
Lymphoma (183)
Machine learning (4)
Management (9)
Manufacturing (160)
MASH (78)
Medical device (3007)
Medtech (3018)
Mergers & acquisitions (3366)
Metabolic disorders (513)
Multiple sclerosis (102)
NASH (12)
Neurodegenerative disease (109)
Neuropsychiatric disorders (49)
Neuroscience (1041)
NextGen: Class of 2026 (1195)
Non-profit (807)
Now hiring (5)
Obesity (252)
Opinion (83)
Ovarian cancer (69)
Pain (60)
Pancreatic cancer (96)
Parkinson's disease (112)
Partnered (5)
Patents (94)
Patient recruitment (202)
Peanut (22)
People (5598)
Pharmaceutical (7)
Pharmacy benefit managers (7)
Phase 1 (8344)
Phase 2 (13948)
Phase 3 (12833)
Pipeline (2346)
Policy (78)
Postmarket research (805)
Preclinical (2200)
Press Release (7)
Prostate cancer (94)
Psychedelics (21)
Radiopharmaceuticals (79)
Rare diseases (301)
Real estate (902)
Recruiting (21)
Regulatory (6947)
Reports (17)
Research institute (489)
Resumes & cover letters (120)
Rett syndrome (6)
RNA editing (3)
RSV (32)
Schizophrenia (81)
Series A (51)
Series B (36)
Service/supplier (1)
Sickle cell disease (32)
Special edition (7)
Spinal muscular atrophy (80)
Sponsored (12)
Startups (633)
Stomach cancer (10)
Supply chain (21)
Tariffs (25)
The Weekly (30)
Vaccines (379)
Venture capital (31)
Weight loss (172)
Women's health (13)
Worklife (6)
Date
Today (3)
Last 7 days (116)
Last 30 days (518)
Last 365 days (9108)
2026 (681)
2025 (9258)
2024 (10253)
2023 (11504)
2022 (14766)
2021 (14952)
2020 (13445)
2019 (10504)
2018 (7801)
2017 (8684)
2016 (7452)
2015 (8899)
2014 (6208)
2013 (4650)
2012 (4873)
2011 (5072)
2010 (4621)
Location
Africa (194)
Alabama (17)
Alaska (1)
Arizona (46)
Arkansas (2)
Asia (11078)
Australia (1812)
California (3372)
Canada (880)
China (373)
Colorado (123)
Connecticut (126)
Delaware (130)
Europe (24336)
Florida (455)
Georgia (127)
Idaho (12)
Illinois (220)
India (12)
Indiana (167)
Iowa (1)
Japan (168)
Kansas (35)
Kentucky (10)
Louisiana (7)
Maine (29)
Maryland (352)
Massachusetts (2256)
Michigan (74)
Minnesota (123)
Mississippi (1)
Missouri (33)
Montana (7)
Nebraska (2)
Nevada (25)
New Hampshire (17)
New Jersey (1196)
New Mexico (3)
New York (943)
North Carolina (323)
Northern California (1748)
Ohio (58)
Oregon (4)
Pennsylvania (661)
Puerto Rico (10)
Rhode Island (8)
South America (282)
South Carolina (10)
Southern California (1260)
Tennessee (42)
Texas (406)
United States (11425)
Utah (70)
Virginia (51)
Washington D.C. (11)
Washington State (246)
Wisconsin (18)
165,783 Results for "second sight".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
July 25, 2025
·
2 min read
Press Releases
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
August 8, 2025
·
16 min read
Press Releases
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026
·
7 min read
Immunology and inflammation
Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026
The Repertoire partnership is Lilly’s second immunology play of the year, after the acquistion of Ventyx in early January for a pipeline of NLRP3 assets.
January 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Sight Sciences to Present at Two Upcoming Investor Conferences - November 4, 2025
November 4, 2025
·
2 min read
Press Releases
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
November 4, 2025
·
4 min read
Press Releases
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
·
2 min read
Press Releases
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
November 6, 2025
·
8 min read
Press Releases
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
November 6, 2025
·
18 min read
Press Releases
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
August 26, 2025
·
2 min read
1 of 16,579
Next
